Rachael Nokes Net Worth

The estimated Net Worth of Rachael Nokes is at least $808 ezer dollars as of 6 August 2024. Ms. Nokes owns over 10,445 units of scPharmaceuticals Inc stock worth over $372,269 and over the last 5 years she sold SCPH stock worth over $0. In addition, she makes $435,673 as Senior Vice President - Finance és Principal Accounting Officer at scPharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Nokes SCPH stock SEC Form 4 insiders trading

Rachael has made over 1 trades of the scPharmaceuticals Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she exercised 10,445 units of SCPH stock worth $53,374 on 6 August 2024.

The largest trade she's ever made was exercising 10,445 units of scPharmaceuticals Inc stock on 6 August 2024 worth over $53,374. On average, Rachael trades about 1,306 units every 0 days since 2020. As of 6 August 2024 she still owns at least 72,851 units of scPharmaceuticals Inc stock.

You can see the complete history of Ms. Nokes stock trades at the bottom of the page.

Rachael Nokes biography

Rachael Nokes serves as Senior Vice President - Finance, Principal Accounting Officer of the Company. Most recently, from 2009 to 2014, Ms. Nokes served as Director of Accounting at BG Medicine, then a publicly held medical device company. Prior to that, from 2001 to 2009, she served in various accounting and finance positions at BG Medicine. From 1998 to 2001, Ms. Nokes held accounting and finance positions at Corning Lasertron and Oak Industries (acquired by Corning). Prior to Oak Industries, Ms. Nokes was an auditor at PriceWaterhouse LLP (now PriceWaterhouseCoopers LLP). Ms. Nokes holds a B.S. in Accounting from Boston College and an M.S. in Finance from Bentley University.

What is the salary of Rachael Nokes?

As the Senior Vice President - Finance és Principal Accounting Officer of scPharmaceuticals Inc, the total compensation of Rachael Nokes at scPharmaceuticals Inc is $435,673. There are 2 executives at scPharmaceuticals Inc getting paid more, with John Tucker having the highest compensation of $1,238,320.

How old is Rachael Nokes?

Rachael Nokes is 45, she's been the Senior Vice President - Finance és Principal Accounting Officer of scPharmaceuticals Inc since 2019. There are 10 older and 1 younger executives at scPharmaceuticals Inc. The oldest executive at scPharmaceuticals Inc is Leonard Schaeffer, 74, who is the Independent Director.

What's Rachael Nokes's mailing address?

Rachael's mailing address filed with the SEC is C/O SCPHARMACEUTICALS INC., 25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA, 01803.

Insiders trading at scPharmaceuticals Inc

Over the last 7 years, insiders at scPharmaceuticals Inc have traded over $5,999,254 worth of scPharmaceuticals Inc stock and bought 6,409,552 units worth $61,370,807 . The most active insiders traders include Capital Management, L.P.Ra ..., Jonathan Silverstein és Advisors Llc Orbi Med Capit.... On average, scPharmaceuticals Inc executives and independent directors trade stock every 112 days with the average trade being worth of $1,808,281. The most recent stock trade was executed by Leonard D Schaeffer on 26 August 2024, trading 11,347 units of SCPH stock currently worth $29,275.

What does scPharmaceuticals Inc do?

scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.

Complete history of Ms. Nokes stock trades at scPharmaceuticals Inc

scPharmaceuticals Inc executives and stock owners

scPharmaceuticals Inc executives and other stock owners filed with the SEC include:

• John Tucker,
  President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer and Director
• John H. Tucker,
  Pres, CEO, Principal Exec. Officer, Principal Financial Officer & Director
• Rachael Nokes,
  Senior Vice President - Finance, Principal Accounting Officer
• Rachael Nokes,
  Sr. VP of Fin. & Principal Accounting Officer
• Jack Khattar,
  Independent Chairman of the Board
• Frederick Hudson,
  Independent Director
• Mette Agger,
  Independent Director
• Klaus Veitinger,
  Independent Director
• Minnie Baylor-Henry,
  Independent Director
• Leonard Schaeffer,
  Independent Director
• Mason Freeman,
  Independent Director
• Katherine Taudvin,
  Director, Corporate Development, Investor Relations
• Sara Bonstein,
  Independent Director
• Michael D. Hassman,
  Sr. VP of Technical Operations
• Dr. John Mohr Pharm.D.,
  Sr. VP of Clinical Devel. & Medical Affairs
• Capital Management, Llcra C...,
  
• Invest A/S Lundbeckfond,
  10% owner
• Advisors Llc Orbi Med Capit...,
  
• Dorothy Coleman,
  Director
• Jonathan Silverstein,
  Director
• Pharmaceutical Industries L...,
  
• Troy A. Ignelzi,
  Chief Financial Officer
• Abraham Ceesay,
  Chief Operating Officer
• Kush Parmar,
  Director
• Andrew J. Schwab,
  10% owner
• Advisors Llc Orbi Med Capit...,
  
• Capital Management, L.P.Ra ...,
  
• Partners Iv, Llc5 Am Co Inv...,
  
• William Tober Abraham,